Axmed has raised $2 million to address supply chain fragmentation in underserved markets and streamline drug supply chains. The startup aims to link manufacturers with health institutions, aggregating demand to enable lower costs and reduce the proliferation of counterfeit drugs. Their initial target markets include Kenya,
•2m read time• From techcrunch.com
Sort: